Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis
Clinical trial NCT02816476 · COMPLETED
Trial details
- NCT number
- NCT02816476
- Sponsor
- University Hospital, Limoges
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-10-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.